Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to get Screeners that run automatically with the results emailed to you! FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Avenue Therapeutics Inc (ATXI)

Avenue Therapeutics Inc (ATXI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Avenue Therapeutics Inc 1111 Kane Concourse Suite 301 Bay Harbor Islands FL 33154 USA

www.avenuetx.com Employees: 3 P: 781-652-4500

Description:

Avenue Therapeutics, Inc. is a specialty pharmaceutical company. It acquires, licenses, develops and commercializes products principally for use in the acute/intensive care hospital setting. Avenue Therapeutics, Inc. is based in New York, United States.

Key Statistics

Overview:

Market Capitalization, $K 3,842
Enterprise Value, $K 2,062
Shares Outstanding, K 1,912
Annual Sales, $ 0 K
Annual Net Income, $ -10,380 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -3,080 K
EBIT, $ -11,810 K
EBITDA, $ -11,810 K
60-Month Beta -0.17
% of Insider Shareholders 1.80%
% of Institutional Shareholders 17.34%
Float, K 1,877
% Float 98.20%
Short Volume Ratio 0.56

Growth:

1-Year Return -86.35%
3-Year Return -99.84%
5-Year Return -99.97%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 96.89%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -1.92 on 11/14/24
Next Earnings Date 11/18/24
Earnings Per Share ttm 18.36
EPS Growth vs. Prev Qtr 70.14%
EPS Growth vs. Prev Year -142.56%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%
Most Recent Split 1-75 on 04/26/24

ATXI Ratios

Ratio
Price/Earnings ttm 0.11
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -471.57%
Return-on-Assets % -296.50%
Profit Margin % 0.00%
Debt/Equity 0.00
Price/Sales N/A
Price/Cash Flow N/A
Price/Book 1.71
Book Value/Share 1.15
Interest Coverage -1.51
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar